BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-5421 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-5421\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07652281-3164@assetmemo.bio
DTSTAMP:20261121T005447Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:SHR-5421: Phase 1 readout est. (NCT07652281)
DESCRIPTION:SHR-5421\, phase 1\, Multiple Myeloma.\nStudy: A Clinical Study
  of SHR-5421 in Patients With Multiple Myeloma\nEstimated primary completi
 on: April 2028. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/shr-5
 421#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT
 07652281
URL:https://assetmemo.bio/drug/shr-5421#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
